Company announces headquarters and all operations moving to San Francisco Bay Area
BURLINGAME, CALIFORNIA, May 1, 2019 — Halo Labs, a life science instrumentation company developing tools for subvisible particle analysis for biopharmaceuticals, today announced the opening of its new headquarters in Burlingame, California. The new headquarters will house sales, marketing, engineering, and manufacturing personnel and serve as the company’s primary Horizon® instrument production facility. With the opening of its new headquarters, Halo Labs also announced its previous headquarters in Philadelphia will be closing by the end of fiscal Q2 2019.
Launched in 2017, the Horizon® system can analyze subvisible and visible particles, including protein aggregates. Using the latest optics and innovative algorithms, it utilizes a plate-based approach that enables high-throughput (up to 96 samples/run), low-volume (as little as 25 µL/sample) particle analysis in a wide-range of pharmaceutical samples from pre-formulation through quality control for a wide range of therapeutics including biologics, vaccines, lipid nanoparticles, and small molecules.
“I am very excited to have Halo Labs right here at home in the San Francisco Bay Area. The talent pool here is fantastic and our growth will be much faster here than anywhere else,” said Robert Wicke, CEO of Halo Labs.